| Trial ID: | L0838 |
| Source ID: | NCT02930161
|
| Associated Drug: |
Runihol
|
| Title: |
Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Runihol;Other: Placebo
|
| Outcome Measures: |
Proportion of responders to treatmentSeverity of dyslipidemia;The insulin resistance index (HOMA-IR);Transaminases;cholestasis markers (alkaline phosphatase, GGT);Bilirubin;Body mass index;ultrasound signs of hepatic steatosis
|
| Sponsor/Collaborators: |
POLYSAN Scientific & Technological Pharmaceutical Company
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
35
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
| Start Date: |
06/10/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Russian Federation
|
| URL: |
https://clinicaltrials.gov/show/NCT02930161
|
